SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest the robust clinical data for its lead pipeline candidate, daraxonrasib, while reacting to the company's significant capital raise. The community is heavily focused on the drug's potential to address high-unmet-need oncological targets, fueling intense speculation regarding a possible acquisition as big pharma continues to seek out late-stage, de-risked assets.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending as investors debate the potential of its real-world asset (RWA) tokenization and payment infrastructure partnerships, with the community actively comparing its early-stage growth to established chains like Solana and XRP. While bulls are heavily accumulating on the expectation that upcoming institutional integration will drive long-term adoption, others remain skeptical, citing concerns over price volatility and the pace of official project announcements.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is currently trending as speculation intensifies regarding potential biotech acquisitions, including companies like Sellas Life Sciences and Inhibrx, as the firm looks to bolster its oncology pipeline ahead of the significant Keytruda patent cliff. The investor community is actively debating the valuation and necessity of these moves, with many tracking Merck's strategic need to secure innovative cancer platforms to maintain its market dominance.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is experiencing heightened volatility as investors weigh a strong earnings beat and raised guidance against concerns over mounting fuel costs that may pressure near-term margins. The stock is a focal point for community debate, with participants divided between those optimistic about the airline's premium travel strength and others wary of the broader economic headwinds impacting the entire sector.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is seeing significant community discussion and market activity surrounding the recent launch of its Sovereign AI Factory, with many investors debating the impact of potential dividend adjustments and capital allocation strategies. The stock remains a polarizing topic as shareholders weigh the company's long-term digital growth initiatives against persistent concerns regarding debt loads and industry-wide pricing pressure.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2024 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is experiencing significant market interest following reports that Apollo-backed Legendary Entertainment is exploring a potential takeover. Investors are actively debating whether this signals a long-awaited acquisition and what a reasonable per-share valuation would be as they speculate on further consolidation in the media sector.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trending as investors monitor the commercial rollout of its lead gene therapy, ZEVASKYN, and analyze the impact of recently activated treatment centers and expanded payer coverage. Community discussions are highly focused on the company's path to profitability, the steady onboarding of new treatment sites, and the significant short interest that many believe is suppressing the stock despite its strong cash position and growth potential.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining community attention as investors highlight its role in the real-world asset sector and its growing adoption by major financial institutions for decentralized data delivery. Discussion centers on the project's transition to a paid service model and its potential as a critical infrastructure layer alongside other prominent oracle networks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF ($SMH) is facing heightened volatility and intense selling pressure as investors grapple with technical breakdowns and rising concerns over the sustainability of AI capital expenditures. While community sentiment remains divided between those hunting for a bottom in hardware leaders and those warning of a broader 'AI bubble' pop, traders are closely monitoring key support levels and institutional rotation into other sectors to gauge if this is a healthy consolidation or a deeper market shift.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The financial sector is currently grappling with a divergence between robust bank earnings driven by investment banking and M&A recovery, and broader concerns over credit quality and commercial real estate exposure. While the community is actively debating whether this represents a sustainable breakout for the sector or a crowded trade due for a reset, institutional flows remain focused on these banks as a pivotal rotation play for the remainder of the year.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

BRNEBorneo Resource Investments Ltd

Latest BRNE News